Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Multispecific anti-HIV duoCAR-T cells display broad in vitro antiviral activity and potent in vivo elimination of HIV-infected cells in a humanized mouse model
  2. Anthony-Gonda, Kim; Bardhi, Ariola; Ray, Alex; Flerin, Nina; Li, Mengyan; Chen, Weizao; Ochsenbauer, Christina; Kappes, John C; Krueger, Winfried; Worden, Andrew; Schneider, Dina; Zhu, Zhongyu; Orentas, Rimas; Dimitrov, Dimiter S; Goldstein, Harris; Dropulic, Boro
  3. Science translational medicine. 2019, Aug 07; 11(504): pii: eaav5685..
  1. 2.   Biochemical and biological studies of mouse APOBEC3
  2. Nair, S.; Sanchez-Martinez, S.; Ji, X.; Rein, A.
  3. Journal of Virology. 2014, Apr; 88(7): 3850-60.
  1. 3.   Mutations that alter the equilibrium between open and closed conformations of Escherichia coli maltose-binding protein impede its ability to enhance the solubility of passenger proteins
  2. Nallamsetty, S.; Waugh, D. S.
  3. Biochemical and Biophysical Research Communications. 2007, Dec; 364(3): 639-644.
  1. 4.   Enhanced soluble protein expression using two new fusion tags
  2. Chatterjee, D. K.; Esposito, D.
  3. Protein Expression and Purification. 2006, MAR; 46(1): 122-129.
  1. 5.   Solubility-enhancing proteins MBP and NusA play a passive role in the folding of their fusion partners
  2. Nallamsetty, S.; Waugh, D. S.
  3. Protein Expression and Purification. 2006, JAN; 45(1): 175-182.
  1. 6.   Gateway vectors for the production of combinatorially-tagged His(6)-MBP fusion proteins in the cytoplasm and periplasm of Escherichia Coli
  2. Nallamsetty, S.; Austin, B. P.; Penrose, K. J.; Waugh, D. S.
  3. Protein Science. 2005, DEC; 14(12): 2964-2971.
  1. 7.   DNA vaccines expressing different forms of simian immunodeficiency virus antigens decrease viremia upon SIVmac251 challenge
  2. Rosati, M.; von Gegerfelt, A.; Roth, P.; Alicea, C.; Valentin, A.; Robert-Guroff, M.; Venzon, D.; Montefiori, D. C.; Markham, P.; Felber, B. K.; Pavlakis, G. N.
  3. Journal of Virology. 2005, JUL; 79(13): 8480-8492.
  1. 8.   Efficient killing of CD22(+) tumor cells by a humanized diabody-RNase fusion protein
  2. Krauss, J.; Arndt, M. A. E.; Vu, B. K.; Newton, D. L.; Seeber, S.; Rybak, S. M.
  3. Biochemical and Biophysical Research Communications. 2005, JUN 3; 331(2): 595-602.
  1. 9.   Making the most of affinity tags
  2. Waugh, D. S.
  3. Trends in Biotechnology. 2005, JUN; 23(6): 316-320.
  1. 10.   A dimeric angiogenin immunofusion protein mediates selective toxicity towards CD22(+) tumor cells
  2. Arndt, M. A. E.; Krauss, J.; Vu, B. K.; Newton, D. L.; Rybak, S. M.
  3. Journal of Immunotherapy. 2005, MAY-JUN; 28(3): 245-251.
  1. 11.   Efficient site-specific processing of fusion proteins by tobacco vein mottling virus protease in vivo and in vitro
  2. Nallamsetty, S.; Kapust, R. B.; Tozser, J.; Cherry, S.; Tropea, J. E.; Copeland, T. D.; Waugh, D. S.
  3. Protein Expression and Purification. 2004, NOV; 38(1): 108-115.
  1. 12.   Chemokine receptor-mediated delivery directs self-tumor antigen efficiently into the class II processing pathway in vitro and induces protective immunity in vivo
  2. Biragyn, A.; Ruffini, P. A.; Coscia, M.; Harvey, L. K.; Neelapu, S. S.; Baskar, S.; Wang, J. M.; Kwak, L. W.
  3. Blood. 2004, OCT 1; 104(7): 1961-1969.
  1. 13.   Oligomerization of the SARS-CoV S glycoprotein: dimerization of the N-terminus and trimerization of the ectodomain
  2. Xiao, X. D.; Feng, Y.; Chakraborti, S.; Dimitrov, D. S.
  3. Biochemical and Biophysical Research Communications. 2004, SEP 10; 322(1): 93-99.
  1. 14.   Expression of the murine leukemia virus protease in fusion with maltose-binding protein in Escherichia coli
  2. Feher, A.; Boross, P.; Sperka, T.; Oroszlan, S.; Tozser, J.
  3. Protein Expression and Purification. 2004 35(1): 62-68.
  1. 15.   Maltodextrin-binding proteins from diverse bacteria and archaea are potent solubility enhancers
  2. Fox, J. D.; Routzahn, K. M.; Bucher, M. H.; Waugh, D. S.
  3. Febs Letters. 2003 537(1-3): 53-57.
  1. 16.   The P1 ' specificity of tobacco etch virus protease
  2. Kapust, R. B.; Tozser, J.; Copeland, T. D.; Waugh, D. S.
  3. Biochemical and Biophysical Research Communications. 2002 294(5): 949-955.
  1. 17.   Solution structure and functional analysis of the cysteine-rich C1 domain of kinase suppressor of Ras (KSR)
  2. Zhou, M.; Horita, D. A.; Waugh, D. S.; Byrd, R. A.; Morrison, D. K.
  3. Journal of Molecular Biology. 2002 315(3): 435-446.
  1. 18.   Preparation of recombinant RNase single-chain antibody fusion proteins
  2. Newton, D. L.; Rybak, S. M.
  3. Molecular Biotechnology. 2002 20(1): 63-76.
  1. 19.   Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens
  2. Biragyn, A.; Surenhu, M.; Yang, D.; Ruffini, P. A.; Haines, B. A.; Klyushnenkova, E.; Oppenheim, J. J.; Kwak, L. W.
  3. Journal of Immunology. 2001 167(11): 6644-6653.
  1. 20.   Tobacco etch virus protease: mechanism of autolysis and rational design of stable mutants with wild-type catalytic proficiency
  2. Kapust, R. B.; Tozser, J.; Fox, J. D.; Anderson, D. E.; Cherry, S.; Copeland, T. D.; Waugh, D. S.
  3. Protein Engineering. 2001 14(12): 993-1000.
  1. 21.   Presence of potential nickel-responsive element(s) in the mouse MTH1 promoter
  2. Liang, R.; Igarashi, H.; Tsuzuki, T.; Nakabeppu, Y.; Sekiguchi, M.; Kasprzak, K. S.; Shiao, Y. H.
  3. Annals of Clinical and Laboratory Science. 2001 31(1): 91-98.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel